BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

262 related articles for article (PubMed ID: 9475486)

  • 1. Therapeutic options for critically ill patients suffering from progressive lupus nephritis or Goodpasture's syndrome.
    Merkel F; Netzer KO; Gross O; Marx M; Weber M
    Kidney Int Suppl; 1998 Feb; 64():S31-8. PubMed ID: 9475486
    [TBL] [Abstract][Full Text] [Related]  

  • 2. The clinical spectrum of acute glomerulonephritis and lung haemorrhage (Goodpasture's syndrome).
    Holdsworth S; Boyce N; Thomson NM; Atkins RC
    Q J Med; 1985 Apr; 55(216):75-86. PubMed ID: 4011844
    [TBL] [Abstract][Full Text] [Related]  

  • 3. A case report of efficiency of double filtration plasmapheresis in treatment of Goodpasture's syndrome.
    Hajime N; Michiko A; Atsunori K; Tatsuo K; Yuko N; Naoki O; Katsuhiko S
    Ther Apher Dial; 2009 Aug; 13(4):373-7. PubMed ID: 19695077
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Characteristics and outcomes of patients with Goodpasture's syndrome.
    Shah MK; Hugghins SY
    South Med J; 2002 Dec; 95(12):1411-8. PubMed ID: 12597309
    [TBL] [Abstract][Full Text] [Related]  

  • 5. [Goodpasture's syndrome].
    Shinjo SK; Hasegawa EM; Costa Malheiros DM; Levy-Neto M
    Acta Reumatol Port; 2008; 33(2):220-3. PubMed ID: 18604188
    [TBL] [Abstract][Full Text] [Related]  

  • 6. [Current aspects of Goodpasture's syndrome].
    Carré P; Rakatoarivony J; Didier A; Lloveras JJ; Léophonte P
    Rev Mal Respir; 1988; 5(4):319-30. PubMed ID: 3051195
    [TBL] [Abstract][Full Text] [Related]  

  • 7. The evolution of crescentic nephritis and alveolar haemorrhage following induction of autoimmunity to glomerular basement membrane in an experimental model of Goodpasture's disease.
    Reynolds J; Moss J; Duda MA; Smith J; Karkar AM; Macherla V; Shore I; Evans DJ; Woodrow DF; Pusey CD
    J Pathol; 2003 May; 200(1):118-29. PubMed ID: 12692850
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Clinical and morphological aspects of the management of crescentic anti-glomerular basement membrane antibody (anti-GBM) nephritis/Goodpasture's syndrome.
    Walker RG; Scheinkestel C; Becker GJ; Owen JE; Dowling JP; Kincaid-Smith P
    Q J Med; 1985 Jan; 54(213):75-89. PubMed ID: 3975346
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Plasmapheresis in glomerulonephritis.
    McKenzie PE; Taylor AE; Woodroffe AJ; Seymour AE; Chan YL; Clarkson AR
    Clin Nephrol; 1979 Sep; 12(3):97-108. PubMed ID: 509788
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Penicillamine-induced "Goodpasture's syndrome": successful treatment of a fulminant case.
    Gavaghan TE; McNaught PJ; Ralston M; Hayes JM
    Aust N Z J Med; 1981 Jun; 11(3):261-5. PubMed ID: 6945838
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Staphylococcal protein A immunoadsorption for Goodpasture's syndrome in four Chinese patients.
    Hu W; Liu Z; Ji D; Xie H; Gong D; Li L
    J Nephrol; 2006; 19(3):312-7. PubMed ID: 16874690
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Immunologic kidney disease.
    Bock GH; Vernier RL
    Am Fam Physician; 1980 Nov; 22(5):87-96. PubMed ID: 6448541
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Treatment options in lupus nephritis.
    McLigeyo SO
    East Afr Med J; 1998 Oct; 75(10):609-13. PubMed ID: 10065198
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Goodpasture's syndrome: a nursing challenge.
    Avella P; Walker M
    Dimens Crit Care Nurs; 1999; 18(2):2-12. PubMed ID: 10640002
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Still a role for plasma exchange in rapidly progressive glomerulonephritis?
    Levy JB; Pusey CD
    J Nephrol; 1997; 10(1):7-13. PubMed ID: 9241619
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Two cases of Goodpasture's syndrome--clinicopathological studies and relapse.
    Kojima K; Okada Y; Kushimoto H; Kawamura N; Katsumata H; Murakami K; Yamasita H; Tomita M; Hasegawa M; Yanai T
    Nihon Jinzo Gakkai Shi; 1993 Jan; 35(1):89-96. PubMed ID: 8336406
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Use of combined plasmapheresis and immunosuppression in the treatment of Goodpasture's syndrome.
    Erickson SB; Kurtz SB; Donadio JV; Holley KE; Wilson CB; Pineda AA
    Mayo Clin Proc; 1979 Nov; 54(11):714-20. PubMed ID: 491763
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Atypical form of Goodpasture's disease.
    Habánová M; Divácká P; Řehořová J; Svobodová I
    Vnitr Lek; 2023; 69(5):316-321. PubMed ID: 37827830
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Goodpasture's syndrome in a patient using cocaine--a case report and review of the literature.
    Sirvent AE; Enríquez R; Andrada E; Amorós F; Gallego JA; González C; Padilla I
    Clin Nephrol; 2007 Sep; 68(3):182-5. PubMed ID: 17915623
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Clinical approach to lupus nephritis: recent advances.
    Molino C; Fabbian F; Longhini C
    Eur J Intern Med; 2009 Sep; 20(5):447-53. PubMed ID: 19712841
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 14.